Updated Jul 16, 2026
Patil Neena M has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $11.67M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | JAZZ | Jazz Pharmaceuticals plc | F — Tax withholding / forfeiture | 2.7K | $237.72 | $637K |
| 2026-06-12 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 1.2K | $231.83 | $278K |
| 2026-06-01 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 1.2K | $236.97 | $282K |
| 2026-05-20 | TFX | TELEFLEX INC | A — Grant or award | 1.1K | $0.00 | |
| 2026-03-09 | JAZZ | Jazz Pharmaceuticals plc | F — Tax withholding / forfeiture | 5.0K | $188.69 | $943K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 197 | $193.60 | $38K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 1.0K | $192.79 | $195K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 1.8K | $191.88 | $342K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 549 | $190.80 | $105K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 1.1K | $190.00 | $202K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 3.5K | $193.58 | $682K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 11.5K | $191.65 | $2.21M |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | A — Grant or award | 10.1K | $0.00 | |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 2.9K | $189.81 | $553K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | M — Option exercise | 2.9K | $137.12 | $400K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 15.6K | $190.28 | $2.96M |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | M — Option exercise | 27.1K | $137.12 | $3.71M |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 875 | $192.07 | $168K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | M — Option exercise | 875 | $113.10 | $99K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 16.6K | $192.53 | $3.20M |
Patil Neena M is a corporate insider — currently tracked as EVP & Chief Legal Officer of Jazz Pharmaceuticals plc (JAZZ). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 14 open-market sales ($11.67M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Patil Neena M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.